Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

Clinical trial NCT01885689 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01885689
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Therapy-Related Myelodysplastic Syndrome

Start date: 2014-02-10
Primary completion: 2019-12-27
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.